0.3944
price up icon2.28%   0.0088
after-market Dopo l'orario di chiusura: .39 -0.0044 -1.12%
loading
Precedente Chiudi:
$0.3856
Aprire:
$0.395101
Volume 24 ore:
103.60K
Relative Volume:
0.01
Capitalizzazione di mercato:
$16.48M
Reddito:
$20.27M
Utile/perdita netta:
$-63.80M
Rapporto P/E:
-0.2595
EPS:
-1.52
Flusso di cassa netto:
$-68.35M
1 W Prestazione:
-2.38%
1M Prestazione:
-12.53%
6M Prestazione:
-10.79%
1 anno Prestazione:
-65.40%
Intervallo 1D:
Value
$0.3887
$0.40
Intervallo di 1 settimana:
Value
$0.3763
$0.4348
Portata 52W:
Value
$0.1417
$1.27

Carisma Therapeutics Inc Stock (CARM) Company Profile

Name
Nome
Carisma Therapeutics Inc
Name
Telefono
(267) 491-6422
Name
Indirizzo
3675 MARKET STREET, PHILADELPHIA
Name
Dipendente
46
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
CARM's Discussions on Twitter

Confronta CARM con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CARM
Carisma Therapeutics Inc
0.3944 16.11M 20.27M -63.80M -68.35M -1.52
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Carisma Therapeutics Inc Stock (CARM) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-12 Downgrade Robert W. Baird Outperform → Neutral
2024-12-10 Downgrade BTIG Research Buy → Neutral
2024-04-11 Iniziato BTIG Research Buy
2023-10-03 Iniziato CapitalOne Overweight
2023-07-06 Iniziato Evercore ISI Outperform
2023-05-31 Aggiornamento Jefferies Hold → Buy
2023-05-24 Iniziato H.C. Wainwright Buy
2023-04-14 Iniziato Robert W. Baird Outperform
Mostra tutto

Carisma Therapeutics Inc Borsa (CARM) Ultime notizie

pulisher
Jul 23, 2025

Carisma Therapeutics Inc. Stock Analysis and ForecastFree Smart Trading Workshop - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Carisma Therapeutics Inc. stockExtraordinary market timing - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Carisma Therapeutics Inc. stock priceFree Stock Market Real-Time Monitoring - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Carisma Therapeutics Inc. a good long term investmentExceptional profit margins - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

Carisma Therapeutics Transfers Listing to Nasdaq Capital Market - TipRanks

Jul 19, 2025
pulisher
Jul 16, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NVEE, CARM, HLGN on Behalf of Shareholders - Benzinga

Jul 16, 2025
pulisher
Jul 16, 2025

How Carisma Therapeutics Inc. stock performs during market volatility200 Percent Profit Outlook - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Carisma Therapeutics Inc. stock price move sharplyFree Top-Rated Stock Analysis - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Carisma Therapeutics Inc. stock attracts strong analyst attentionFree VIP Investment Strategies - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: TURN, HLGN, CARM, and GNTY - The Malaysian Reserve

Jul 14, 2025
pulisher
Jul 05, 2025

Investor Rights Law Firm Investigates Couchbase, Carisma, Enzo Biochem Merger Deals. - AInvest

Jul 05, 2025
pulisher
Jul 04, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE - The Malaysian Reserve

Jul 04, 2025
pulisher
Jun 30, 2025

Carisma Therapeutics Inc. (NASDAQ:CARM) Given Average Recommendation of “Hold” by Brokerages - Defense World

Jun 30, 2025
pulisher
Jun 27, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Jun 27, 2025
pulisher
Jun 27, 2025

Deal Watch: Novartis To Develop Cardiovascular Therapies With ProFound - insights.citeline.com

Jun 27, 2025
pulisher
Jun 26, 2025

Carisma Therapeutics and OrthoCellix Merge to Advance Regenerative Cell Therapy for Orthopedic Diseases - MSN

Jun 26, 2025
pulisher
Jun 25, 2025

After laying off most of its staff, struggling Carisma Therapeutics finds a merger partner - The Business Journals

Jun 25, 2025
pulisher
Jun 24, 2025

Carisma Therapeutics, OrthoCellix enter definitive merger agreement - Yahoo Finance

Jun 24, 2025
pulisher
Jun 23, 2025

Carisma Therapeutics stock soars after proposed merger with OrthoCellix - Investing.com India

Jun 23, 2025
pulisher
Jun 22, 2025

CARISMA Therapeutics Plummets 12%: What Drives a Crash Without News? - AInvest

Jun 22, 2025
pulisher
Jun 21, 2025

Carisma Therapeutics' 12% Drop: A Mystery Unveiled Through Order Flow and Peer Dynamics - AInvest

Jun 21, 2025
pulisher
Jun 20, 2025

CARISMA Therapeutics Plunges 10.36% Amid Market Volatility - AInvest

Jun 20, 2025
pulisher
Jun 15, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Shares Sold by Millennium Management LLC - Defense World

Jun 15, 2025
pulisher
Jun 15, 2025

Carisma Therapeutics, Inc. (NASDAQ:CARM) Stock Position Decreased by Millennium Management LLC - Defense World

Jun 15, 2025
pulisher
Jun 15, 2025

Millennium Management LLC Takes Position in Marker Therapeutics, Inc. (NASDAQ:MRKR) - Defense World

Jun 15, 2025
pulisher
Jun 12, 2025

Carisma Therapeutics Secures Nasdaq Listing Approval - TipRanks

Jun 12, 2025
pulisher
Jun 11, 2025

Is the 250% Carisma Therapeutics Stock (CARM) Surge a Sucker’s Rally? - The Globe and Mail

Jun 11, 2025
pulisher
Jun 11, 2025

Dow Rises Over 50 Points; US Inflation Rate Increases In May - Benzinga

Jun 11, 2025
pulisher
Jun 11, 2025

Carisma Therapeutics Stock (CARM) Retreats 35% After a Massive Rally - TipRanks

Jun 11, 2025
pulisher
Jun 10, 2025

US Stocks Mixed; JM Smucker Shares Plunge After Q4 Results - Benzinga

Jun 10, 2025
pulisher
Jun 10, 2025

Pre-market Movers: EVGN, WINT, CARM, UNCY... - RTTNews

Jun 10, 2025
pulisher
Jun 10, 2025

Why Casey's General Stores Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket - Benzinga

Jun 10, 2025

Carisma Therapeutics Inc Azioni (CARM) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):